1. Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance
   Xueyang Hu et al, 2023, Frontiers in Oncology CrossRef
2. HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer
   Han Zhang et al, 2021, Cancer Science CrossRef
3. Hormone resistance and breast cancer in young women: Correlated factors and survival impact
   Wala Ben Kridis et al, 2020, The Breast Journal CrossRef
4. Estrogen receptor α (ERα) status evaluation using RNAscope in situ hybridization: a reliable and complementary method for IHC in breast cancer tissues
   Xiuwei Yu et al, 2017, Human Pathology CrossRef
5. Prognostic Value of Estrogen and Progesterone Receptor Expression in Low Proliferative Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
   Yujin Lee et al, 2017, Journal of Breast Disease CrossRef